The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - A multicenter prospective trial

Journal of Hepatology

Volumn 54, Issue 2, 2011, Pages 219-226

  Huang, Jee Fu ^a,b,c   Yu, Ming Lung ^b,d,e   Huang, Chung Feng ^c,e   Chiu, Chang Fu ^f   Dai, Chia Yen ^b,d   Huang, Ching I ^c,g   Yeh, Ming Lun ^b   Yang, Jeng Fu ^b   Hsieh, Ming Yen ^b,e   Hou, Nai Jen ^a   Lin, Zu Yau ^b,d   Chen, Shinn Cherng ^b,d   Wang, Liang Yen ^b,d   Chuang, Wan Long ^b,d  

^a KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e KAOHSIUNG MUNICIPAL TA TUNG HOSPITAL   (Taiwan)

^f Pao Chien Hospital   (Taiwan)

^g Pingtung Hospital   (Taiwan)

Author keywords

Hepatitis C virus; Hepatocellular carcinoma; Pegylated interferon alpha; Ribavirin

Indexed keywords

PEGINTERFERON ALPHA2A; RIBAVIRIN; VIRUS RNA;

ADULT; ANEMIA; ANOREXIA; ANXIETY; ARTICLE; ASTHMA; BACTERIAL INFECTION; BACTERIAL PERITONITIS; CASE CONTROL STUDY; CHRONIC HEPATITIS; DEPRESSION; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ESOPHAGUS VARICES BLEEDING; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; HAIR LOSS; HEPATITIS C; HUMAN; INSOMNIA; IRRITABILITY; LEUKOPENIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MORTALITY; MOUTH CANCER; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NAUSEA; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; RETINA DETACHMENT; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT RESPONSE; VERTIGO; VIRUS HEPATITIS; VIRUS LOAD;

AGED; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; RIBAVIRIN; VIRAL LOAD;

EID: 78751578865     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.07.011     Document Type: Article

References (30)

1. G.C. Farrell New hepatitis C guidelines for the Asia-Pacific region: APASL consensus statements on the diagnosis, management and treatment of hepatitis C virus infection J Gastroenterol Hepatol 22 2007 607 610
2. M.G. Ghany, D.B. Strader, D.L. Thomas, and L.B. Seeff Diagnosis, management, and treatment of hepatitis C: an update Hepatology 49 2009 1335 1374
3. L.B. Seeff Natural history of chronic hepatitis C Hepatology 36 2002 S35 S46
4. M.L. Yu, C.F. Huang, C.Y. Dai, J.F. Huang, and W.L. Chuang Long-term effects of interferon-based therapy for chronic hepatitis C Oncology 72 2007 16 23
5. G.M. Lauer, and B.D. Walker Hepatitis C virus infection N Engl J Med 345 2001 41 52
6. W.L. Chuang, M.L. Yu, C.Y. Dai, and W.Y. Chang Treatment of chronic hepatitis C in southern Taiwan Intervirology 49 2006 99 106
7. J.F. Huang, M.L. Yu, C.M. Lee, C.Y. Dai, N.J. Hou, and M.Y. Hsieh Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1, 386-patient study from Taiwan Aliment Pharmacol Ther 25 2007 1029 1037
8. M.L. Yu, S.M. Lin, C.M. Lee, C.Y. Dai, W.Y. Chang, and S.C. Chen A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy Hepatology 44 2006 1086 1097
9. M.L. Yu, S.M. Lin, W.L. Chuang, C.Y. Dai, J.H. Wang, and S.N. Lu A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan Antivir Ther 11 2006 985 994
10. M.L. Yu, and W.L. Chuang Treatment of chronic hepatitis C in Asia: when East meets West J Gastroenterol Hepatol 24 2009 336 345
11. M. Omata, H. Yoshida, and Y. Shiratori Prevention of hepatocellular carcinoma and its recurrence in chronic hepatitis C patients by interferon therapy Clin Gastroenterol Hepatol 3 2005 S141 S143
12. Y. Shiratori, Y. Ito, O. Yokosuka, F. Imazeki, R. Nakata, and N. Tanaka Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival Ann Intern Med 142 2005 105 114
13. H. Okamoto, H. Tokita, M. Sakamoto, M. Horikita, M. Kojima, and H. Iizuka Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection J Gen Virol 74 1993 2385 2390
14. R.G. Knodell, K.G. Ishak, W.C. Black, T.S. Chen, R. Craig, and N. Kaplowitz Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis Hepatology 1 1981 431 435
15. P. Bedossa, and T. Poynard An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group Hepatology 24 1996 289 293
16. B. Helbling, W. Jochum, I. Stamenic, M. Knopfli, A. Cerny, and J. Borovicka HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirin J Viral Hepat 13 2006 762 769
17. L. Roffi, G. Colloredo, P. Pioltelli, G. Bellati, M. Pozzpi, and P. Parravicini Pegylated interferon-alpha2b plus ribavirin: an efficacious and well-tolerated treatment regimen for patients with hepatitis C virus related histologically proven cirrhosis Antivir Ther 13 2008 663 673
18. S. Missiha, J. Heathcote, T. Arenovich, and K. Khan Impact of Asian race on response to combination therapy with peginterferon alfa-2a and ribavirin in chronic hepatitis C Am J Gastroenterol 102 2007 2181 2188
19. M.L. Yu, C.Y. Dai, J.F. Huang, N.J. Hou, L.P. Lee, and M.Y. Hsieh A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C Gut 56 2007 553 559
20. M.L. Yu, C.Y. Dai, J.F. Huang, C.F. Chiu, Y.H. Yang, and N.J. Hou Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trial Hepatology 47 2008 1884 1893
21. Y. Tanaka, N. Nishida, M. Sugiyama, M. Kurosaki, K. Matsuura, and N. Sakamoto Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat Genet 41 2009 1105 1109
22. D. Ge, J. Fellay, A.J. Thompson, J.S. Simon, K.V. Shianna, and T.J. Urban Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401
23. C.F. Huang, J.F. Yang, C.Y. Dai, J.F. Huang, N.J. Hou, and M.Y. Hsieh Efficacy and safety of pegylated interferon combined with ribavirin for the treatment of older patients with chronic hepatitis C J Infect Dis 201 2010 751 759
24. A. Floreani, V. Baldo, E.R. Rizzotto, I. Carderi, T. Baldovin, and E. Minola Pegylated interferon alpha-2b plus ribavirin for naive patients with HCV-related cirrhosis J Clin Gastroenterol 42 2008 734 737
25. V. Di Marco, P.L. Almasio, D. Ferraro, V. Calvaruso, G. Alaimo, and S. Peralta Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension: a randomized controlled trial J Hepatol 47 2007 484 491
26. J.I. Arenas, and H.E. Vargas Hepatitis C virus antiviral therapy in patients with cirrhosis Gastroenterol Clin North Am 33 2004 549 562
27. E.J. Heathcote, M.L. Shiffman, W.G. Cooksley, G.M. Dusheiko, S.S. Lee, and L. Balart Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis N Engl J Med 343 2000 1673 1680
28. J.M. Moreno Planas, E. Rubio Gonzalez, E. Boullosa Grana, M. Fernandez Ruiz, M. Jimenez Garrido, and J.L. Lucena de la Poza Effectiveness of pegylated interferon and ribavirin in patients with liver HCV cirrhosis Transplant Proc 37 2005 1482 1483
29. A.S. Lok, L.B. Seeff, T.R. Morgan, A.M. di Bisceglie, R.K. Sterling, and T.M. Curto Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease Gastroenterology 136 2009 138 148
30. J. Ji, J. Shi, A. Budhu, Z. Yu, M. Forgues, and S. Roessler MicroRNA expression, survival, and response to interferon in liver cancer N Engl J Med 361 2009 1437 1447